Inuprin Forte (Inosine Pranobex)

The compound enhances the host immune response by stimulating cytokine production (including interferon‑γ and interleukin‑2), increasing natural killer cell activity, and up‑regulating major histocompatibility complex expression. These actions improve viral clearance while also exerting direct antiviral effects that interfere with viral replication.

The dosage of Inuprin Forte is determined by the prescribing clinician based on the specific indication, patient age, weight, and clinical condition. Physicians may adjust the regimen according to therapeutic response and tolerability, following local prescribing guidelines.

Safety data for Inosine Pranobex in pregnancy and lactation are limited. It is generally recommended to avoid use during pregnancy unless the potential benefit justifies the risk, and to exercise caution while breastfeeding, monitoring the infant for any adverse effects.

To place an order, submit an enquiry on the Inuprin Forte product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with nucleoside analogues such as acyclovir, Inosine Pranobex acts primarily as an immunomodulator rather than a direct viral DNA polymerase inhibitor. This broader mechanism can be advantageous for infections where immune enhancement is beneficial, but it may have a different side‑effect profile and drug‑interaction considerations.

Store Inuprin Forte at room temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and potency throughout its shelf life.

Inuprin Forte is taken orally. The tablets or capsules should be swallowed whole with a glass of water, preferably with or without food as directed by the prescriber. Patients should follow the dosing schedule provided by their healthcare professional.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, significant liver enzyme elevations indicating hepatic stress, and hematologic abnormalities like thrombocytopenia or anemia. Prompt medical attention is required if any of these symptoms develop.

Inuprin Forte should be avoided in individuals with known hypersensitivity to Inosine Pranobex or any excipients, patients with severe liver disease, and those who are pregnant unless the benefit outweighs the risk. Caution is also advised for patients receiving live vaccines or potent immunosuppressive therapy.